Celegene, Juno collaborate to develop cancer therapies
June 29, 2015 at 16:20 PM EDT
June 29 (Reuters) - Celgene Corp and Juno Therapeutics Inc said they signed a deal to develop and commercialize immunotherapies for the treatment of cancer and autoimmune diseases.
